308 related articles for article (PubMed ID: 34987199)
1. LRG1 as a novel therapeutic target in eye disease.
De Rossi G; Da Vitoria Lobo ME; Greenwood J; Moss SE
Eye (Lond); 2022 Feb; 36(2):328-340. PubMed ID: 34987199
[TBL] [Abstract][Full Text] [Related]
2. LRG1 Expression Is Elevated in the Eyes of Patients with Neovascular Age-Related Macular Degeneration.
Mundo L; Tosi GM; Lazzi S; Pertile G; Parolini B; Neri G; Posarelli M; De Benedetto E; Bacci T; Silvestri E; Siciliano MC; Barbera S; Orlandini M; Greenwood J; Moss SE; Galvagni F
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445590
[TBL] [Abstract][Full Text] [Related]
3. Early Enhanced Leucine-Rich
Haku S; Wakui H; Azushima K; Haruhara K; Kinguchi S; Ohki K; Uneda K; Kobayashi R; Matsuda M; Yamaji T; Yamada T; Minegishi S; Ishigami T; Yamashita A; Ohashi K; Tamura K
Biomed Res Int; 2018; 2018():2817045. PubMed ID: 30515388
[TBL] [Abstract][Full Text] [Related]
4. Modulation of transforming growth factor-β-induced kidney fibrosis by leucine-rich ⍺-2 glycoprotein-1.
Hong Q; Cai H; Zhang L; Li Z; Zhong F; Ni Z; Cai G; Chen XM; He JC; Lee K
Kidney Int; 2022 Feb; 101(2):299-314. PubMed ID: 34774561
[TBL] [Abstract][Full Text] [Related]
5. Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration.
Van Hove I; Hu TT; Beets K; Van Bergen T; Etienne I; Stitt AW; Vermassen E; Feyen JHM
Prog Retin Eye Res; 2021 Nov; 85():100966. PubMed ID: 33775825
[TBL] [Abstract][Full Text] [Related]
6. LRG1: an emerging player in disease pathogenesis.
Camilli C; Hoeh AE; De Rossi G; Moss SE; Greenwood J
J Biomed Sci; 2022 Jan; 29(1):6. PubMed ID: 35062948
[TBL] [Abstract][Full Text] [Related]
7. The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases.
Van Bergen T; Etienne I; Cunningham F; Moons L; Schlingemann RO; Feyen JHM; Stitt AW
Prog Retin Eye Res; 2019 Mar; 69():116-136. PubMed ID: 30385175
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma and vitreous levels of leucine-rich-α2-glycoprotein are associated with diabetic retinopathy progression.
Chen C; Chen X; Huang H; Han C; Qu Y; Jin H; Niu T; Zhang Y; Liu K; Xu X
Acta Ophthalmol; 2019 May; 97(3):260-264. PubMed ID: 29168314
[TBL] [Abstract][Full Text] [Related]
9. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
Nguyen QD; De Falco S; Behar-Cohen F; Lam WC; Li X; Reichhart N; Ricci F; Pluim J; Li WW
Acta Ophthalmol; 2018 Feb; 96(1):e1-e9. PubMed ID: 27874278
[TBL] [Abstract][Full Text] [Related]
10. Collaborative Regulation of LRG1 by TGF-β1 and PPAR-β/δ Modulates Chronic Pressure Overload-Induced Cardiac Fibrosis.
Liu C; Lim ST; Teo MHY; Tan MSY; Kulkarni MD; Qiu B; Li A; Lal S; Dos Remedios CG; Tan NS; Wahli W; Ferenczi MA; Song W; Hong W; Wang X
Circ Heart Fail; 2019 Dec; 12(12):e005962. PubMed ID: 31830829
[TBL] [Abstract][Full Text] [Related]
11. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
[TBL] [Abstract][Full Text] [Related]
12. The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure.
Song W; Wang X
Biophys Rev; 2015 Mar; 7(1):91-104. PubMed ID: 28509980
[TBL] [Abstract][Full Text] [Related]
13. Current perspectives on established and novel therapies for pathological neovascularization in retinal disease.
Campbell M; Doyle SL
Biochem Pharmacol; 2019 Jun; 164():321-325. PubMed ID: 31039332
[TBL] [Abstract][Full Text] [Related]
14. Anti-VEGF Therapy for Diabetic Eye Diseases.
Bahrami B; Hong T; Gilles MC; Chang A
Asia Pac J Ophthalmol (Phila); 2017; 6(6):535-545. PubMed ID: 29076303
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of APE1/Ref-1 for Neovascular Eye Diseases: From Biology to Therapy.
Hartman GD; Lambert-Cheatham NA; Kelley MR; Corson TW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638620
[TBL] [Abstract][Full Text] [Related]
16. Latrophilin-2 is a novel receptor of LRG1 that rescues vascular and neurological abnormalities and restores diabetic erectile function.
Yin GN; Kim DK; Kang JI; Im Y; Lee DS; Han AR; Ock J; Choi MJ; Kwon MH; Limanjaya A; Jung SB; Yang J; Min KW; Yun J; Koh Y; Park JE; Hwang D; Suh JK; Ryu JK; Kim HM
Exp Mol Med; 2022 May; 54(5):626-638. PubMed ID: 35562586
[TBL] [Abstract][Full Text] [Related]
17. LRG1 Contributes to the Pathogenesis of Multiple Kidney Diseases: A Comprehensive Review.
Chen C; Zhang J; Yu T; Feng H; Liao J; Jia Y
Kidney Dis (Basel); 2024 Jun; 10(3):237-248. PubMed ID: 38799248
[TBL] [Abstract][Full Text] [Related]
18. A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.
Cehofski LJ; Honoré B; Vorum H
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452939
[TBL] [Abstract][Full Text] [Related]
19. A Multifunctional Role of Leucine-Rich α-2-Glycoprotein 1 in Cutaneous Wound Healing Under Normal and Diabetic Conditions.
Liu C; Teo MHY; Pek SLT; Wu X; Leong ML; Tay HM; Hou HW; Ruedl C; Moss SE; Greenwood J; Tavintharan S; Hong W; Wang X
Diabetes; 2020 Nov; 69(11):2467-2480. PubMed ID: 32887674
[TBL] [Abstract][Full Text] [Related]
20. Targeting Angiopoietin in Retinal Vascular Diseases: A Literature Review and Summary of Clinical Trials Involving Faricimab.
Khan M; Aziz AA; Shafi NA; Abbas T; Khanani AM
Cells; 2020 Aug; 9(8):. PubMed ID: 32785136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
